← All Sponsors
SPONSOR

Hebei Senlang Biotechnology Inc., Ltd.

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Acute Lymphoblastic LeukemiaLymphomaMultiple Myeloma
NCT05618041
Recruiting

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Acute Lymphoblastic Leukemia
China View Trial →